Edition:
United Kingdom

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

753.40INR
10:28am GMT
Change (% chg)

Rs-1.65 (-0.22%)
Prev Close
Rs755.05
Open
Rs758.00
Day's High
Rs759.90
Day's Low
Rs747.05
Volume
1,204,781
Avg. Vol
1,856,753
52-wk High
Rs986.10
52-wk Low
Rs723.65

Chart for

About

Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central... (more)

Overall

Beta: -0.05
Market Cap(Mil.): Rs469,414.59
Shares Outstanding(Mil.): 451.84
Dividend: 7.50
Yield (%): 0.72

Financials

  LUPN.NS Industry Sector
P/E (TTM): 23.14 29.30 32.54
EPS (TTM): 44.89 -- --
ROI: -- 14.23 13.82
ROE: -- 15.46 15.25

UPDATE 1-India's Lupin posts Q3 loss on charge related to blood pressure drug

Feb 6 Indian drugmaker Lupin Ltd posted a surprise quarterly loss on Wednesday after taking a one-time charge related to litigation over a blood pressure drug.

06 Feb 2019

India's Lupin posts quarterly loss on one-off charge

Feb 6 Indian drugmaker Lupin Ltd posted a surprise third-quarter loss on Wednesday, due to a one-off charge in the quarter.

06 Feb 2019

UPDATE 1-India's Lupin Q2 profit dives as U.S. sales, higher expenses weigh

Oct 31 Lupin Ltd, India's second-largest drugmaker by revenue, posted a lower-than-expected second-quarter profit on Wednesday, as sales in the United States - a key market - dropped and overall manufacturing costs rose.

31 Oct 2018

India's Lupin Q2 profit falls, misses estimates

Oct 31 Lupin Ltd, India's second-largest drugmaker by revenue, posted a 41.5 percent fall in second-quarter profit on Wednesday, hurt by higher expenses.

31 Oct 2018

Earnings vs. Estimates